Credit Suisse’s Bionano Genomics BNGO Stock Holding History

Credit Suisse’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-391	Closed	-$260K	–	3172
2023 Q1	$260K	Hold	391	–	–	﹤0.01%	3044
2022 Q4	$342K	Buy	391 +7	+2%	+$8.81K	﹤0.01%	2971
2022 Q3	$421K	Buy	384 +60	+19%	+$79.3K	﹤0.01%	2889
2022 Q2	$268K	Sell	324 -1	-0.3%	-$1.03K	﹤0.01%	3213
2022 Q1	$502K	Buy	325 +27	+9%	+$36.4K	﹤0.01%	2970
2021 Q4	$535K	Sell	298 -5	-2%	-$13.4K	﹤0.01%	3765
2021 Q3	$999K	Buy	303 +27	+10%	+$94.4K	﹤0.01%	3343
2021 Q2	$1.22M	Buy	+276	New	+$1.09M	﹤0.01%	3235

Other funds holding BNGO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Credit Suisse's BNGO Position: Q2 2023 in Review

Credit Suisse sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 391 shares — an estimated $260K sold.

Credit Suisse first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $1.22M in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

Credit Suisse reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 391 Bionano Genomics shares in Q2 2023, an estimated $260K.
Credit Suisse first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
Credit Suisse's Bionano Genomics position peaked at $1.22M in Q2 2021.
108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.